Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Maj 2014

Planlagt Fastgjort Låst Flyttet Genmab
1.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • investor1989I Offline
    investor1989I Offline
    investor1989
    wrote on sidst redigeret af
    #546

    men derfor skal der nok være nogle af os nørder der finder dataene selv inden genmab sender dem ud 🙂

    1 Reply Last reply
    0
    • J Offline
      J Offline
      JKY_VH
      wrote on sidst redigeret af
      #547

      og det er vi meget taknemmelige for:-)

      1 Reply Last reply
      0
      • R Offline
        R Offline
        Repsac
        wrote on sidst redigeret af
        #548

        Specielt hvis du finder dem inden børsen lukker

        1 Reply Last reply
        0
        • SolsenS Offline
          SolsenS Offline
          Solsen
          wrote on sidst redigeret af
          #549

          Udnyttelse af warrants - 58.000 nye aktier, der sikkert skal sælges i morgen...

          1 Reply Last reply
          0
          • investor1989I Offline
            investor1989I Offline
            investor1989
            wrote on sidst redigeret af
            #550

            Der går et par dage før de nye aktier bliver registreret hos Erhvervsstyrelsen og kan sælges

            1 Reply Last reply
            0
            • investor1989I Offline
              investor1989I Offline
              investor1989
              wrote on sidst redigeret af
              #551

              så nok først i næste uge du vil se salgene. Så må vi håbe ASCO dataene i aften giver købspres imorgen. Nogen som har link til hvor de bliver frigivet?

              1 Reply Last reply
              0
              • D Offline
                D Offline
                dohk
                wrote on sidst redigeret af
                #552

                http://abstracts.asco.org

                1 Reply Last reply
                0
                • SolsenS Offline
                  SolsenS Offline
                  Solsen
                  wrote on sidst redigeret af
                  #553

                  Det kan vel registreres elektronisk på webreg eller virk.dk med øjeblikkelig virkning. Men lad os være fælles i håbet om at vi kl 23.00 kan glæde os over mange cr etc....

                  1 Reply Last reply
                  0
                  • SolsenS Offline
                    SolsenS Offline
                    Solsen
                    wrote on sidst redigeret af
                    #554

                    46% ORR i 16 mg gruppen i monoforsøget. Heraf 2 pts kun en dosering.

                    1 Reply Last reply
                    0
                    • D Offline
                      D Offline
                      dohk
                      wrote on sidst redigeret af
                      #555

                      Så er de online http://abstracts.asco.org/144/CatView_144_B.html

                      1 Reply Last reply
                      0
                      • SolsenS Offline
                        SolsenS Offline
                        Solsen
                        wrote on sidst redigeret af
                        #556

                        http://abstracts.asco.org/144/AbstView_144_127438.html

                        1 Reply Last reply
                        0
                        • investor1989I Offline
                          investor1989I Offline
                          investor1989
                          wrote on sidst redigeret af
                          #557

                          Sanofis kombo data med Revlimid er ikke mega stærke: The ORR (≥ PR), according to IMWG criteria, among 12 evaluable pts was 58 %. Responses occurred at each DL of 3mg/kg (1PR), 5mg/kg (1PR, 1 VGPR) and 10 mg/kg (1PR, 3 VGPR).

                          1 Reply Last reply
                          0
                          • investor1989I Offline
                            investor1989I Offline
                            investor1989
                            wrote on sidst redigeret af
                            #558

                            pt. ingen CR !!!!!!!

                            1 Reply Last reply
                            0
                            • investor1989I Offline
                              investor1989I Offline
                              investor1989
                              wrote on sidst redigeret af
                              #559

                              DARA+LEN+DEX has favorable safety profile with manageable toxicities in relapsed and RR MM. Encouraging early activity is seen with marked reduction in M-protein and 8/11 patients (72%) achieving PR or better. Part 2 data will be presented

                              1 Reply Last reply
                              0
                              • investor1989I Offline
                                investor1989I Offline
                                investor1989
                                wrote on sidst redigeret af
                                #560

                                SAR overall response rate er ikke mega god. http://abstracts.asco.org/144/AbstView_144_129808.html kun 33% ORR i patienter behandlet med over 10 mg. de har dog 11% CR i de patienter. men stadigvæk.. Dara har noget højere ORR dog lavere CR

                                1 Reply Last reply
                                0
                                • SolsenS Offline
                                  SolsenS Offline
                                  Solsen
                                  wrote on sidst redigeret af
                                  #561

                                  http://abstracts.asco.org/144/AbstView_144_133856.html SAR ... Ja ikke skræmmende i konkurrencen

                                  1 Reply Last reply
                                  0
                                  • investor1989I Offline
                                    investor1989I Offline
                                    investor1989
                                    wrote on sidst redigeret af
                                    #562

                                    OMFG tjek lige Ibrutinib+Arzerra kombi data. de er outstanding: Overall response rate in CLL/SLL was 100%

                                    1 Reply Last reply
                                    0
                                    • SolsenS Offline
                                      SolsenS Offline
                                      Solsen
                                      wrote on sidst redigeret af
                                      #563

                                      Arzerra er markant undervurderet af analytikerne

                                      1 Reply Last reply
                                      0
                                      • investor1989I Offline
                                        investor1989I Offline
                                        investor1989
                                        wrote on sidst redigeret af
                                        #564

                                        http://abstracts.asco.org/144/AbstView_144_132436.html At study end, 52/58 responders (90%) remained progression-free with f/u of 16, 12 and 11 months for G1, 2 and 3, respectively

                                        1 Reply Last reply
                                        0
                                        • investor1989I Offline
                                          investor1989I Offline
                                          investor1989
                                          wrote on sidst redigeret af
                                          #565

                                          det er i fuckin 72 patienter de leverer så høj en ORR

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger